Midgard Science

Dinamiqs

Zurich, Switzerland dinamiqs.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

DINAMIQS is a viral vector CDMO focused on AAV and lentiviral vectors for gene therapy and cell therapy programs. It provides development, analytical, fill-finish, and GMP manufacturing services from R&D through commercial supply. The company is headquartered in Schlieren, Zurich, Switzerland.

Services

  • Adeno associated virus (AAV) development and manufacturing

    End-to-end AAV support from R&D to commercial supply, including lead vector optimization, process development, and GMP manufacturing.

  • Lentiviral vector (LV) development and manufacturing

    End-to-end lentiviral vector support from R&D to commercial supply for ex vivo and in vivo programs, including process development and GMP manufacturing.

  • Analytical services

    In-house assays for characterization of AAV and LV products, including identity, purity, potency, strength, safety, and method development.

  • Fill-finish

    In-house aseptic vial filling for AAV and LV drug products using semi-automated isolator technology.

    CDMO: development & manufacturing

  • Distinctive services and technologies

    AI-enabled vector optimization, proprietary capsids, flexible cell line strategies, digital quality systems, and regulatory expertise to support program development.

  • Off the shelf vectors

    Ready-to-use AAV vectors and reference materials including reporter gene vectors, empty capsids, and rcAAV standards.

Turnaround
Up to cGMP production in just 7–9 months
What to send
  • DNA
  • Plasmids
  • Reagents

Capabilities

Assays and studies
  • AAV
  • Lentivirus
  • Fill-finish
  • Cell therapy
  • In vivo
  • Process development
17 more
  • Analytical development
  • Bioreactors
  • qPCR
  • dPCR
  • Capsid ELISA
  • p24 ELISA
  • SLS-UV/VIS
  • NGS
  • SDS-PAGE
  • Alkaline gel electrophoresis
  • Mass photometry
  • DLS
  • SEC-HPLC
  • HCP ELISA
  • Hc-DNA qPCR
  • Residual plasmid dPCR
  • TCID50
Scale and capacity
  • cGMP production
  • Process robustness verification in 2L bioreactors
  • Small batches of viral vector drug product
  • Filling from <1 mL to 50 mL vials
Therapeutic areas
  • Gene therapy
  • Cell therapy

Instruments and platforms

  • SKAN Pure isolator technology
  • AT Filler Crystal® Pure M1

Modalities and species

Modalities
  • Antibody
  • Viral vector
  • Cell therapy

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: viral vector manufacturing

Details

Type
CDMO
Office
Wagistrasse 18 8952 Schlieren, Switzerland
Sites
Schlieren, Switzerland
Serves
Europe, worldwide, global accessibility

Similar labs